Navigation Links
Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
Date:5/19/2011

AUBURNDALE, Mass., May 19, 2011 /PRNewswire/ -- Advantagene, Inc., a Massachusetts-based biopharmaceutical company, announced today that it reached an agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment (SPA) for a pivotal Phase 3 clinical trial of ProstAtak™, its lead agent for patients with newly diagnosed prostate cancer. The trial is expected to accrue 711 patients starting mid-2011 with definitive results expected by 2015. The randomized study will evaluate ProstAtak's ability to prevent prostate cancer recurrence. If successful, it could yield the first drug product for newly diagnosed, localized prostate cancer.

Prostate cancer is the second most common cause of death in American men. The American Cancer Society estimates there were approximately 220,000 new prostate cancer diagnoses in 2010. And, although most patients will live at least 5 years after diagnosis, each year over 60,000 men develop recurrence of the cancer and 32,000 die of their disease.

"The SPA and initiation of this pivotal study are aimed at addressing a critical unmet medical need," said Dr. Estuardo Aguilar-Cordova, Founder and CEO of Advantagene. "If successful, ProstAtak would be the first-ever product to vaccinate against the recurrence of a cancer, in this case prostate cancer."

Since no curative therapy currently exists for recurrent prostate cancer, only palliative treatments that compromise quality of life, such as surgical or medical castration, are employed. Once these approaches fail, options include the recently approved immunotherapy Provenge® (Dendreon) or the chemotherapies Zytiga® (Johnson & Johnson) and Jevtana® (Sanofi), which provide modest survival improvements. Advantagene researchers have taken another approach entirely, i.e. preventing prostate cancer death by preventing recurrence. ProstAtak™ is designed as an "off-the-shelf" drug to kill tumor cells and stimulate a vaccine e
'/>"/>

SOURCE Advantagene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
2. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
3. ShangPharma Announces First Quarter 2011 Results
4. BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting
5. Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
6. Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Submission of Biologics Master File for Recombinant CRM197 to US FDA
7. ACT Announces Oregon Health & Science University as Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration
8. InterMune Announces Presentation of Positive Pirfenidone Data at the International Conference of the American Thoracic Society (ATS)
9. Spherix Announces First Quarter Financial Results
10. Stem Cell Assurance Announces the Filing of Its Form 10 Registration Statement
11. 3SBio Inc. Announces Unaudited First Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... TAMPA, Fla. , May 6, 2015  Oxis ... International, Inc. OTC: OXIS, OXI.PA, announced today that ... Oncology, Division of Cancer Medicine at the University of ... board.  Dr. Yee is also Professor, Department of Immunology, ... Therapy, Center for Cancer Immunology Research at the University ...
(Date:5/6/2015)... 2015 Dr Jaspreet Singh , Senior ... deliver a speech at the 2015 Asian Starch Conference, to ... Expo Center.  , ... the topic: ,Potato Starch: A Potential Source for the ... Co-editor of a 528 page text book entitled ...
(Date:5/5/2015)... AND TORONTO, May 5, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... reported financial results for the three months ended March ... otherwise, all amounts are in Canadian dollars. ... fiscal year end from May 31 to December 31. ... period being reported is for the three months ended ...
(Date:5/5/2015)... Hayden-McNeil is pleased to announce ... materials for smaller courses. This program is specifically designed ... students. , “I’m very excited about offering our ... instructors,” said Jeff McCarthy, Hayden-McNeil president. “By working with ... part to make education both more effective and affordable.” ...
Breaking Biology Technology:Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Potato Starch: A Potential Source for the Creation of Next Generation Bulk-ingredients and Smart Foods 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2
... ... 5 Days Global Jatropha Hi-Tech Agricultural Training Programme (JWTP10) in India from SEPTEMBER ... as Global Jatropha Hi-Tech Agricultural Training Programme for Development of Sustainable Non-Food Jatropha ... ...
... that, under the right conditions, newly developed nanocrystalline ... between the geometric clusters of atoms called nanocrystals ... detailed recently in the journal Science , ... ubiquitous in the fabrication of microdevices and integrated ...
... ... global research initiative to create the next generation of fertilizers and production technologies, with ... ... 23, 2010 -- IFDC is launching the Virtual Fertilizer Research Center (VFRC), ...
Cached Biology Technology:CJP Announces 5 Days Global Jatropha Hi-Tech Agricultural Training Programme in India from SEPTEMBER 20-24, 2010 2CJP Announces 5 Days Global Jatropha Hi-Tech Agricultural Training Programme in India from SEPTEMBER 20-24, 2010 3CJP Announces 5 Days Global Jatropha Hi-Tech Agricultural Training Programme in India from SEPTEMBER 20-24, 2010 4CJP Announces 5 Days Global Jatropha Hi-Tech Agricultural Training Programme in India from SEPTEMBER 20-24, 2010 5Stressed nanomaterials display unexpected movement 2IFDC Launches Virtual Fertilizer Research Center 2IFDC Launches Virtual Fertilizer Research Center 3IFDC Launches Virtual Fertilizer Research Center 4IFDC Launches Virtual Fertilizer Research Center 5
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, ... control and security systems is pleased to announce that ... as a consultant and member of its scientific advisory ... widely known as a thought leader in technology-enhanced learning ... Technology Group, and has published studies and books focused ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2
... Diego, CA (March 18, 2009) Epidemiologists and computer ... create a new low-cost, green technology for automatically tracking ... enter and after they exit patient rooms. This ... essential for infection control in hospitals, was released today ...
... choose their mates based on fancy feathers. Female mammals, ... follow their noses to the right mate. That,s one ... Katherine McAuliffe, whose review of evidence for female mate ... The Quarterly Review of Biology . Historically, ...
... Cliff I. Davidson, Joseph B. Kadane and Nanjun Chu ... East End areas of Pittsburgh are more affected by ... Because more than three-quarters of particulate matter found in ... mainly to the west the importance of ...
Cached Biology News:Pilot study shows effectiveness of new, low-cost method for monitoring hand hygiene compliance 2Female mammals follow their noses to the right mates 2Carnegie Mellon researchers apply new statistical test 2
Mouse monoclonal [H4B4] to LAMP2 - Lysosome Marker (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 3920 SwissProtID: P13473...
... NIS-Elements revolutionizes imaging software for the ... to microscopes, cameras, components and peripherals ... achiving tools. Its intuitive interface simplifies ... times while providing powerful features such ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
Vented Caps for 75 cm2 Flasks...
Biology Products: